Delivery Order 75N95023D00021-75N95024F00001
Award Date 4/12/24
Potential Completion Date 10/31/25
Potential Value $301K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
St Peters, MO 63304, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a task order award under the National Institute on Drug Abuse's (NIDA) IDIQ contract No. HHSN271201800024I for receptor binding and predictive toxicology services. The award, valued at $291,884.01, was issued to Eurofins Discovery Services North America, LLC, a foreign-owned for-profit contract research organization. The task order is for work described under the NIDA contract with a period of performance from April 3, 2020 to April 2, 2021. The contract was awarded on a firm-fixed-price...
- This is a $132,771.58 firm-fixed-price delivery order contract awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to Eurofins Discovery Services North America, LLC, a foreign-owned for-profit contract research organization. The contract is for receptor profile screening services in support of NIDA's drug abuse research programs. It has a period of performance from June 25, 2025 to June 24, 2026. The contract is not set aside for any small...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse (NIDA) awarded a $401,178.36 firm fixed-price delivery order to Eurofins Panlabs, Inc., a foreign-owned, for-profit contract research organization. The contract is for receptor profiling and predictive toxicology services to support NIDA's research initiatives. This task order was issued under a larger $5 million IDIQ contract from NIDA for receptor binding services, which includes...
- This is a federal contract award from the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to Eurofins Discoverx Corporation, a foreign-owned for-profit organization. The contract is for $301,894.16 in firm fixed-price services related to testing lead compounds for additional characterization and reagent development. The contract does not have a set-aside designation. Eurofins Discoverx Corporation is a provider of innovative cell-based...
- The National Institute on Drug Abuse (NIDA) awarded a $249,093.62 firm fixed-price delivery order to Eurofins Discovery Services North America, LLC on September 21, 2025, for receptor profile screening services. The contract runs through September 20, 2026, and represents work performed at the contractor's facility in St. Peters, Missouri. This delivery order is issued under NIDA's existing $5 million Indefinite Delivery Vehicle (IDV) for receptor binding and predictive toxicology services,...
- This is a $142,193 cost-plus-fixed-fee task order awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS), to Eurofins Panlabs, Inc., a foreign-owned for-profit contract research organization. The task order is for receptor binding and predictive toxicology services to support drug discovery research, with a period of performance from September 26, 2023 to September 25, 2024. Eurofins...
- This is a firm fixed-price delivery order issued by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse (NIDA) to Eurofins Panlabs, Inc., a foreign-owned for-profit contract research organization. The $359,131 order is for a 1-year period of performance from September 30, 2020 to September 29, 2021 under the NIDA N01DA-18-8937 contract vehicle. The work involves receptor binding and predictive toxicology services to support NIDA's drug...
- The U.S. National Institute on Drug Abuse (NIDA) has awarded a firm-fixed-price purchase order contract worth $20,217.10 to Eurofins Panlabs, Inc., a foreign-owned, for-profit contract research organization. The contract, which does not have a set-aside designation, is for the provision of various research and development services to support NIDA's drug abuse research programs. These services include receptor binding studies, predictive toxicology, safety pharmacology, and non-clinical research....
- This federal contract award to Eurofins Discoverx Corporation, a foreign-owned for-profit organization, is for the provision of specialized cell-based assays, reagents, and services to support drug discovery and research. The $13,482.10 firm fixed-price purchase order was awarded by the Midwest Area of the U.S. Department of Health and Human Services, which includes agencies such as the National Institutes of Health (NIH). The contract is for the delivery of PathHunter HTR2A GPCR internalization...
- This delivery order, awarded May 1, 2018, provides nonclinical services for the development of interventional agents targeting infectious diseases through the National Institute of Allergy and Infectious Diseases (NIAID). Eurofins Discovery Services North America, LLC, a foreign-owned contract research organization headquartered in St. Charles, Missouri, was awarded this firm-fixed-price delivery order with a ceiling value of $1.21 million and an ultimate completion date of April 30, 2025. The...